Elevation Oncology Inc. (ELEV) NASDAQ
$3.88 (0.44) (-10.18%)
Market Cap: $210.17M
As of 04/24/24 04:00 PM EDT. Market closed.
Elevation Oncology Inc. (ELEV)
NASDAQ
$3.88
(0.44) (-10.18%)
Market Cap: $210.17M
As of 04/24/24 04:00 PM EDT. Market closed.
Add to Portfolio
elevation oncology is founded on the belief that every patient with cancer deserves to know what is driving the growth of their disease and have access to therapeutics that can stop it. we make genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of disease. together with our peers we work towards a future in which each ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
34
Address
.
PRICE CHART FOR ELEVATION ONCOLOGY INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$4.30
Previous Close
$4.32
Days Range
$3.88 - $4.33
52 week range
$0.36 - $5.89
Volume
658,115
Avg. Volume (30 days)
872,245
Market Cap
$210.17M
Dividend Yield
-
P/E
-
Shares Outstanding
48,651,115
Open
$4.30
Previous Close
$4.32
Days Range
$3.88 - $4.33
52 week range
$0.36 - $5.89
Volume
658,115
Avg. Volume (30 days)
872,245
Market Cap
$210.17M
Dividend Yield
-
P/E
-
Shares Outstanding
48,651,115
FINANCIAL STATEMENTS FOR ELEVATION ONCOLOGY INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ELEVATION ONCOLOGY INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | Mar 16, 2024 | Option Exercise | $4.39 | 4,773 | 20,953 | 85,680 | Mar 19, 2024, 04:10 PM |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | Dec 16, 2023 | Option Exercise | $0.51 | 4,773 | 2,434 | 77,891 | Dec 19, 2023, 04:15 PM |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | Sep 16, 2023 | Option Exercise | $0.73 | 4,773 | 3,475 | 70,101 | Sep 19, 2023, 04:15 PM |
| Ferra Joseph J Jr | INTERIM CEO & CFO | Jun 16, 2023 | Option Exercise | $1.47 | 4,773 | 7,016 | 62,312 | Jun 21, 2023, 04:06 PM |
| Ferra Joseph J Jr | INTERIM CEO & CFO | Mar 16, 2023 | Option Exercise | $2.35 | 4,773 | 11,217 | 54,522 | Mar 20, 2023, 04:21 PM |
| Ferra Joseph J Jr | CHIEF FINANCIAL OFFICER | Dec 16, 2022 | Option Exercise | $0.95 | 4,773 | 4,534 | 46,732 | Dec 19, 2022, 07:40 PM |
| Ferra Joseph J Jr | CHIEF FINANCIAL OFFICER | Sep 16, 2022 | Option Exercise | $1.25 | 4,773 | 5,966 | 38,943 | Dec 19, 2022, 07:40 PM |
| Ferra Joseph J Jr | CHIEF FINANCIAL OFFICER | Jun 16, 2022 | Option Exercise | $1.26 | 19,095 | 24,060 | 31,154 | Dec 19, 2022, 07:40 PM |
| venBio Global Strategic Fund III, L.P. | 10% Owner | May 25, 2022 | Sale | $4.12 | 702,737 | 2,897,806 | 1,905,430 | May 27, 2022, 07:20 PM |
| Qiming U.S. Healthcare Fund II, L.P. | 10% Owner | Jun 29, 2021 | Buy | $16.00 | 312,500 | 5,000,000 | 2,370,142 | Jul 01, 2021, 07:45 PM |
| Aisling Capital IV, LP | 10% Owner | Jun 29, 2021 | Buy | $16.00 | 187,500 | 3,000,000 | 2,834,910 | Jul 01, 2021, 06:29 PM |
| venBio Global Strategic Fund III, L.P. | 10% Owner | Jun 29, 2021 | Buy | $16.00 | 625,000 | 10,000,000 | 2,608,167 | Jul 01, 2021, 05:27 PM |
| Cormorant Asset Management, LP | Former 10% Owner | Jun 29, 2021 | Buy | $16.00 | 250,000 | 4,000,000 | 2,233,168 | Jul 01, 2021, 04:24 PM |
| Vertex Global HC Fund II Pte. Ltd. | 10% Owner | Jun 29, 2021 | Buy | $16.00 | 250,000 | 4,000,000 | 2,307,642 | Jun 29, 2021, 04:07 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | 03/16/2024 | 20,953 |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | 12/16/2023 | 2,434 |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | 09/16/2023 | 3,475 |
| Ferra Joseph J Jr | INTERIM CEO & CFO | 06/16/2023 | 7,016 |
| Ferra Joseph J Jr | INTERIM CEO & CFO | 03/16/2023 | 11,217 |
| Ferra Joseph J Jr | CHIEF FINANCIAL OFFICER | 12/16/2022 | 4,534 |
| Ferra Joseph J Jr | CHIEF FINANCIAL OFFICER | 09/16/2022 | 5,966 |
| Ferra Joseph J Jr | CHIEF FINANCIAL OFFICER | 06/16/2022 | 24,060 |
| venBio Global Strategic Fund III, L.P. | 10% Owner | 05/25/2022 | 2,897,806 |
| Qiming U.S. Healthcare Fund II, L.P. | 10% Owner | 06/29/2021 | 5,000,000 |
| Aisling Capital IV, LP | 10% Owner | 06/29/2021 | 3,000,000 |
| venBio Global Strategic Fund III, L.P. | 10% Owner | 06/29/2021 | 10,000,000 |
| Cormorant Asset Management, LP | Former 10% Owner | 06/29/2021 | 4,000,000 |
| Vertex Global HC Fund II Pte. Ltd. | 10% Owner | 06/29/2021 | 4,000,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ELEVATION ONCOLOGY INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 1,500,000 | 0.02% | No change | Other |
| RENAISSANCE TECHNOLOGIES LLC | 441,490 | 0.00037% | New | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 230,136 | 0.00001% | No change | Other |
| BLACKROCK INC. | 80,676 | 0% | 115.56% | Other |
CHANGE IN SHARES OUTSTANDING FOR ELEVATION ONCOLOGY INC
STOCK BUYBACKS FOR ELEVATION ONCOLOGY INC
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-19.63%
1Q
06/30/2023
23.58%
2Q
12/31/2022
46.24%
4Q
09/30/2022
46.32%
5Q
06/30/2022
46.52%
6Q
03/31/2022
46.78%
7Q
09/30/2021
47.43%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ELEVATION ONCOLOGY INC
LOADING...